UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Phase 2

Terminated

Conditions: Castration-Resistant Prostate Carcinoma
Double-Negative Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions: Drug: Abiraterone Acetate
Drug: Enzalutamide
Drug: Erdafitinib

First Posted Date: 2019-06-26

Last Posted Date: 2023-09-28

Lead Sponsor: University of Washington

Target Recruit Count: 3

Registration Number: NCT03999515

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Veterans Nature Therapy (Vet Hike)

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorders

Interventions: Behavioral: Group urban hikes
Behavioral: Group nature hikes

First Posted Date: 2019-06-25

Last Posted Date: 2021-06-14

Lead Sponsor: University of Washington

Target Recruit Count: 26

Registration Number: NCT03997344

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1

Completed

Conditions: Recurrent B Acute Lymphoblastic Leukemia
Refractory B Lymphoblastic Lymphoma
Recurrent B Lymphoblastic Lymphoma
Refractory B Acute Lymphoblastic Leukemia

Interventions: Drug: Etoposide
Drug: Doxorubicin
Drug: Vincristine
Drug: Prednisone
Drug: Cyclophosphamide
Biological: Inotuzumab Ozogamicin

First Posted Date: 2019-06-19

Last Posted Date: 2023-07-06

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT03991884

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Imaging for SIJ Injection Therapy

Not Applicable

Withdrawn

Conditions: Sacroiliitis
Sacroiliac Joint Pain

Interventions: Other: sacroiliac joint injection

First Posted Date: 2019-06-19

Last Posted Date: 2021-05-05

Lead Sponsor: University of Washington

Registration Number: NCT03992053

Locations: 🇺🇸
UW Center for Pain Relief, Seattle, Washington, United States

Developing Low-Cost Universal Malnutrition Screening for Low Income Countries - the MAMMS Trial

Not Applicable

Conditions: Child Malnutrition

Interventions: Other: Maternal Administered Malnutrition Monitoring System (MAMMS)

First Posted Date: 2019-05-29

Last Posted Date: 2020-01-13

Lead Sponsor: University of Washington

Target Recruit Count: 1200

Registration Number: NCT03967015

Locations: 🇰🇪
Migori County Referral Hospital, Migori, Kenya
🇰🇪
Homa Bay County Referral Hospital, Homa Bay, Kenya
🇰🇪
Nyatike (Macalder) Sub-County Hospital, Macalder, Kenya

Motivating Campus Change Project Pilot Study

Not Applicable

Completed

Conditions: Drinking Behavior

Interventions: Behavioral: Sequential Post Feedback Intervention Delivery
Behavioral: Simultaneous Post Feedback Intervention Delivery
Behavioral: Text Message Boosters

First Posted Date: 2019-05-24

Last Posted Date: 2020-12-16

Lead Sponsor: University of Washington

Target Recruit Count: 250

Registration Number: NCT03962751

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Harm Reduction for Tobacco Smoking With Support of Tobacco-Replacing Electronic Nicotine Delivery Systems

Not Applicable

Conditions: Smoking, Tobacco

Interventions: Other: Standard Care (SC)
Other: HaRTS-TRENDS

First Posted Date: 2019-05-24

Last Posted Date: 2019-05-24

Lead Sponsor: University of Washington

Target Recruit Count: 94

Registration Number: NCT03962660

Locations: 🇺🇸
University of Washington - Harborview Medical Center, Seattle, Washington, United States

Best Management of Muscle Relaxation- Objective Monitoring

Phase 4

Completed

Conditions: Residual Paralysis, Post Anesthesia

Interventions: Combination Product: Protocol for Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex

First Posted Date: 2019-05-21

Last Posted Date: 2022-11-02

Lead Sponsor: University of Washington

Target Recruit Count: 200

Registration Number: NCT03958201

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

University of Washington Reading & Dyslexia Research Program

Conditions: Reading Disability

Interventions: Behavioral: preK

First Posted Date: 2019-05-10

Last Posted Date: 2019-05-10

Lead Sponsor: University of Washington

Target Recruit Count: 44

Registration Number: NCT03945097

Locations: 🇺🇸
University of Washignton, Seattle, Washington, United States

Efficacy of a Brief Intervention for School Clinicians (BRISC)

Not Applicable

Conditions: Academic Performance
Emotional/Behavioral Function

Interventions: Behavioral: SAU
Behavioral: BRISC

First Posted Date: 2019-05-06

Last Posted Date: 2019-05-06

Lead Sponsor: University of Washington

Target Recruit Count: 850

Registration Number: NCT03939208

Locations: 🇺🇸
University of Washington School Mental Health Assessment, Research, and Training (SMART) Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy